Coagulation testing, also known as clotting testing, is a diagnostic procedure used to evaluate the blood’s ability to form clots properly. These tests are crucial for identifying bleeding disorders, monitoring patients on anticoagulant therapy, and assessing liver function. Common types of coagulation tests include Prothrombin Time (PT), Activated Partial Thromboplastin Time (aPTT), and the International Normalized Ratio (INR). These tests help detect conditions such as hemophilia, deep vein thrombosis, and disseminated intravascular coagulation. Abnormal results may indicate a risk of excessive bleeding or unwanted clotting, both of which can have serious health consequences. Coagulation tests are typically conducted using a blood sample drawn from a vein, and results can guide clinical decisions in surgery, trauma care, or chronic disease management. The increasing prevalence of cardiovascular diseases, the aging population, and the widespread use of blood thinners are driving the demand for coagulation testing. Advances in point-of-care testing devices have further improved access and convenience, enabling faster diagnosis and treatment. Laboratories and hospitals rely on both manual and automated analyzers to ensure accurate and timely results, making coagulation testing a vital tool in modern healthcare diagnostics.   View More Trending Titles: - https://www.emergenresearch.com/industry-report/polymer-dispersions-market   https://www.emergenresearch.com/industry-report/bot-services-market   https://www.emergenresearch.com/industry-report/business-jets-market   https://www.emergenresearch.com/industry-report/hepatitis-testing-market   https://www.emergenresearch.com/industry-report/enterprise-performance-management-market